20th International Conference on Pharmaceutical Medicine
ΗΜ/ΝΙΑ & ΩΡΑ:
19 Οκτωβρίου, 2022 - 21 Οκτωβρίου, 2022 Όλη τη μέρα
ΤΟΠΟΘΕΣΙΑ:
Κέντρο Πολιτισμού Ίδρυμα Σταύρος Νιάρχος
Λεωφ. Ανδρέα Συγγρού 364,, Καλιθέα, Αττική, 176 74
περιγραφη συνεδριου
What lies ahead in Pharmaceutical Medicine.
Trends Reigniting Biomedical Research & Disruptive Technologies, Accelerating R&D and Advancing Clinical Medicine
ΟΜΙΛΗΤΕΣ
Juan Jose Abellan Data Analytics and Methods Task Force, Scientific Lead for DARWIN EU, EMA
Roisin Adams MPharm, MSc, PhD, Head of HTA Strategy and External Engagement NCPE, Full Member of the EUnetHTA Executive Board
Grigorios Agkyralidis PharmD, Regulatory Affairs Head, Boehringer Ingelheim, Greece
Dimitris Agrafiotis PhD, Vice President Digital Worldwide Research Development and Medical Affairs, Pfizer
Anna Aletra Senior Trial Manager, Clinical Development Center Poland, Novo Nordisk
Enrica Alteri Former head of Safety and Efficacy, EMA
Kostas Athanasakis Assistant Professor of Health Economics and Health Technology Assessment, Department of Public Health, University of West Attica
Dimitrios Athanasiou Patient representative at the PDCO
Persephone Augoustidou – Savvopoulou President, KRIKOS ZOIS Patient Association
Flora Bacopoulou Assoc. Professor of Pediatrics-Adolescent Medicine, Head of Center for Adolescent Medicine, UNESCO Chair in Adolescent Health Care, 1st Dpt of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Aghia Sophia Children’s Hospital, Greece HTA Committee President
Varvara Baroutsou MD, PhD, GFMD, EMAUD, Consultant Internal Medicine, Pharmaceutical Medicine, President EL.E.F.I., IFAPP President Elect
Andreas Beust Chief Scientific Officer, GCP-Service International Ltd. & Co. KG
Laura Biven PhD, Branch Chief for Integrated Infrastructure and Emerging Technologies, Office of Data Science Strategy Division of Program Coordination, Planning and Strategic Initiatives Office of the Director National Institutes of Health
Donato Bonifazi EPTRI coordinator
Matt Britland MD, Medical Director, Amgen; President, Australian Pharmaceutical medical and scientific Professionals Association (APPA)
David Brown Statistician, Medicines and Healthcare products Regulatory Agency (MHRA) MHRA-Licensing
Theodora Calogeropoulou Research Director Institute of Chemical Biology (ICB), National Hellenic Research Foundation
Clare Campbell Senior Digital Strategy and Solutions, Labcorp
Athanasios Chaniotis BSc in Chemistry, Strategic Alliances Manager, J&J Greece
Magda Chatzikou PhD, Partner PharmEcons Easy Access, SEP Hellenic Open University Health Care Management, Partners at HORIZON 2020 in Healthcare Programme
Jaya Chidambaram BSc (Hons), MBBS, MRCOphth, PhD, Lead Medical Director, Roche Products Limited, UK
Francis Crawley BPhil, Executive Director, Good Clinical Practice Alliance (GCPA) & SIDCER
Christina Dalla PhD, Associate Professor of Pharmacology, Neuropsychopharmacology group, Medical School, National & Kapodistrian University of Athens, President-elect of the Mediterranean Neuroscience Society, Member of the Board of Directors European Brain Foundation
Nikos Dedes President, Greek Patients Association
Meletios Athanasios Dimopoulos Hematologist-Medical Oncologist, Chairman of the Department of Clinical Therapeutics, Rector of the National and Kapodistrian University of Athens
Nikolas Dovrolis MSc, PhD, Post-Doctoral Researcher, Laboratory of Pharmacology, Individualised Medicine & Pharmacological Research Solutions Center (IMPReS), Department of Medicine, Democritus University of Thrace,
Alexandroupolis, Greece
Victoria Elegant Adjunct Prof. MBBS, DRCOG, FPM, FFPM, Vice President, Medical Affairs, Amgen Asia Pacific; Global Lead, Access to Medicines, Amgen; President Asia Pacific, Medical Affairs Professional Society Advisor,
FPM Global
Eugenia Fouza PharmD, ex Deputy Head of National Medicines Agency, Pharmaceutical Studies and Research Division
Brigitte Franke-Bray MD, PhD, FFPM GFMD, Specialist in Pharmaceutical Medicine FMH, Treasurer IFAPP
Shayesteh Fürst-Ladani MBA, MSc, GFMD, Senior Vice President SFL, Head of SFL Group
Mina Gaga MD, PhD, Deputy Minister of Health, Ministry of Health, Greece
Ricardo Gaminha Pacheco Consultant 4SC AG
Silvia Garcia Senior Manager Regulatory, Drug development & Manufacturing, EFPIA
Silke Gastine Pharmacometrics Expert, Sanofi, Germany
Jan Geissler Padvocates, Germany
Evangelos Giamarellos-Bourboulis MD, PhD, FISAC, Professor of Internal Medicine, Director: Master (MSc) Program of Infectious Diseases, 4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece
Luca Giraldi Scientific expert, Data Analytics and Methods Task Force, European Medicines Agency
Georgia Gkegka PRAC alt. member, Special Scientific Personnel, Pharmacovigilance Department, National Organisation for Medicines, Greece
Ghazaleh Gouya Priv. Doz. Dr med, Cardiologist, Founder of Gouya Insights, GPMed Board Member and IFAPP Board Member
Achilleas Gravanis Professor of Pharmacology, School of Medicine University of Crete, Researcher IMBB-FORTH, Affiliated Research Professor, Center of Drug Discovery, Northeastern University, Boston, USA
Melisa Harris Associate Director Patient Relations, Recruitment, Engagement, Labcorp
Anne-Sophie Henry-Eude Head of Document Access and Publication Department, EMA
Heidrun Hildebrand Pediatric Development Alliance Manager, Bayer AG
Peter Hovstadius MD, PhD, Life Science Consultant, Science Communication Trainer
Kyoko Imamura MD PhD, DrMedSci, GFMD, IFAPP Past President, Visiting Professor Tokyo University, Japan
Christina Kanaka-Gantenbein MD, PhD, FMH(CH), Professor of Pediatrics-Pediatric Endocrinology Director, First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, Aghia Sophia Children’s Hospital Athens, Greece
Haralambos Karanikas Assistant Professor, Department of Computer Science and Biomedical Informatics, University of Thessaly, Greece
Sandor Kerpel-Fronius MD, DSc, FFPM, Semmelweis University, Department of Pharmacology and Pharmacotherapy, Budapest, Hungary
Ingrid Klingmann MD, PhD, Chairman at EFGCP, President at PharmaTrain Federation, Managing Director at Pharmaplex
Leonidas Klironomos Pharmacist, MSc (Biostatistics), Acting Head, Clinical Trials Department, Pharmaceutical Studies and Research Division, National Organization for Medicines, Greece
Otmar Kloiber MD, PhD, Secretary General of the World Medical Association
Olaf Klungel Professor of Pharmacoepidemiologic Methods, Head of the division of Pharmacoepidemiology & Clinical Pharmacology (PECP), Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, the Netherlands
Theofilos Kolletis Professor in Cardiology, University of Ioannina, Greece
Christos Kontogiorgis Associate Professor Health and Environmental Protection, Medical School of Alexandroupolis, Democritus University, ENCePP expert, Greece
Dimitris Kontopidis Vice President, Greek Patients Association, General Director, Humane Social Enterprise
Evagelia Koraki President HACRO
Thanassis Kotsanis Cardiologist, Medical Director GR&CY/ Cluster Medical Director Southern Mediterranean & Black Sea, Bayer AG
Ioannis Kotsiopoulos Secretary General for Health Services, Ministry of Health, Greece
Katerina Koutsogianni Former President, Vice President, Greek Patients Association
Stamatiki Kritas BSc Hons, Business Development Manager, Hellenic Biocluster (Hbio)
Chieko Kurihara BSocSc, specially appointed Professor, Kanagawa Dental University, and Member of the IFAPP Ethics Working Group
Cordula Landgraf Director Communication and Stakeholder Engagement, SCTO, Switzerland; Member of IFAPP Board of Officers
Ilhak Lee MD, PhD, Associate Professor, Department of Medical Law and Ethics, College of Medicine, Yonsei University, Seoul, Korea
Birka Lehmann Senior Expert for Drug Regulatory Affairs and Lecturer at the University of Bonn, Germany
Adamantia Maniatakou Chemistry BSc, PhD, Patient Safety Specialist, Deputy of Patient Safety Head, Global Drug Development, Novartis
Vangelis Manolopoulos Professor, Laboratory of Pharmacology, Medical School, Democritus University of Thrace, and Clinical Pharmacology and Precision Medicine Unit, Academic General Hospital of Evros, Greece
Kotone Matsuyama JAPhMed Professor, Department of Health Policy and Management, and Vice President of Center for Strategic Research Initiative, Nippon Medical School & IFAPP Ethics Group Chair
Aggelina Mavraki Clinical Studies’ Unit Head, Sanofi Greece
Christoph Meier MD, Head, Department of Internal Medicine, University Hospital Zürich, Switzerland
Tomas Melvin Associate Professor of Medical Device Regulatory Affairs, Trinity College Dublin, Ireland
Derick Mitchell CEO of IPPOSI, Ireland
Annette Mollet PhD, dipl. Pharm. Med. SwAPP, MBA, Head of Education & Training of the European Center of Pharmaceutical Medicine at the University of Basel, Switzerland
Alex Moulis PhD, Medical Director, Sandoz
Pantelis Natsiavas Researcher, Head of eHealth Lab Institute of Applied Biosciences, Centre of Research and Technology Hellas (INAB CERTH), Greece
Markos Ollandezos Scientific Director, Panhellenic Pharmaceutical Association
Elena Panitti MD, Global Head RWE Excellence Novartis, Basel, Switzerland
Konstantina Papageorgiou PhD, Molecular Biologist, Director, Project Delivery, ICON
Andreas Papapetropoulos BPharm, PhD, FAHA, FBPhS, Professor & Director, Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens; EPHAR Secretary General
Georgios Pappas Physician, Institute of Continuing Medical Education of Ioannina, Greece
Ioannis Petrovas BSc Chemistry, EL.E.F.I. Secretary General; Medical Operations Specialist, Medical Dept, AbbVie
Johannes Pleiner-Duxneuner President, GPMed (Austrian association of Pharmaceutical Medicine)
John Policarpio Immediate Past President of the Philippine College of Pharmaceutical Medicine and Medical Director at United Laboratories, Inc.
Maria Polydorou PharmD, MSc Clinical Pharmacy, Director of Pfizer’s Pharmacovigilance Departments for Southeastern Europe (Cluster Safety Lead for SEEU)
Lembit Rago MD, PhD, Secretary General, Council for International Organizations of Medical Sciences (CIOMS), Geneva, Switzerland
Jack Resneck President of the American Medical Association (AMA)
Marco Romano MD, PhD, GFMD, IFAPP President
Grigorios Rombopoulos MD, Specialist in Endocrinology, CSO Novartis Greece
Georgios Rompolas Cardiologist; Clinical, Regulatory and Medical Director, Novo Nordisk
Mihai Rotaru Senior Manager Market Access, EFPIA
Eleonora Sarikou BSc Biology, MBA, Pharmacovigilance & Regulatory Manager, Medical Department GlaxoSmithKline Greece
Veronique Schaaf Pharmacist, EL.E.F.I. Treasurer
Ali Shehzad MBBS, MPH, MSc (MStats), PhD, Canada Research Chair in Public Health Economics, Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, Canada; Visiting Associate Professor, University of York, UK; Visiting Associate Professor, Macquarie University, Australia
Effie Simou Assistant Professor Communication and Mass Media in Public Health, Health Policies, University of West Attika, Athens, Greece
Dominique Sprumont Prof. University of Neuchatel, Chairman Research Ethics Committee of the Canton of Vaud, Switzerland
Eugena Stamuli Founding Partner, PharmEcons Easy Access Ltd., Visiting Research Fellow, University of York, UK
Peter Stonier PhD, FFPM, FMedSci, Director of Specialty Training at the Faculty of Pharmaceutical Medicine, UK
Karthick Sukumaran Technology Enablement Director Intelligent Safety Automation, Roche
Elyse I. Summers, JD President and CEO, Association for the Accreditation of Human Research Protections Programs, Inc.
Constantin Tamvakopoulos PhD, Investigator – Professor Level, Clinical, Experimental Surgery & Translational Research Lab Head, Biomedical Research Foundation of the Academy of Athens
Stefanos Tarazis MD, PhD, Deputy Head of National Medicines Agency, Pharmaceutical Research & Studies
Nektarios Tavernarakis Chairman, Foundation for Research and Technology-Hellas; Professor, Medical School, University of Crete; Vice President, European Research Council; Chairman, European Institute of Innovation and Technology
Steffen Thirstrup European Medicines Agency Chief Medical Officer
George Tousimis Pharma Innovation Forum, Vice President Greece
Nikos Tsokanas Medical Digital Lead EMEA, Bayer
Christina Tsougkou PharmD, Safety Value Partner, Roche Hellas
Kataryna Uspenska Senior Clinical Project Manager, Gouya Insights
Vera Vazaiou Senior Manager/Central Monitor Oversight Lead, Amgen
Sriram Venkateswaran Senior Safety Data Scientist, Roche
Takis Vidalis PhD, Lawyer, Member of the European Group on Ethics in Science and New Technologies (EGE – European Commission)